On July 6, 2018, the 39th National Pharmaceutical Industry QC Group Results Publication Exchange meeting sponsored by China Pharmaceutical Quality Management Association and hosted by Yangzijiang Pharmaceutical Group Sichuan Haihui Pharmaceutical Co., Ltd. ended in Chengdu, Sichuan, and more than 600 results from more than 200 enterprises in the national pharmaceutical industry participated in the publication.
With the impressive performance of 102 QC results first prize, Yangzijiang Pharmaceutical Group once again won the total number of QC results first prize "crown", and won the national pharmaceutical industry QC results first prize "fourteen consecutive titles".
The topics of this presentation are as follows:
Morning Bell QC team | To establish a microbial limit test method for AB tablets | Quality management department |
Woodpecker QC Team | Reduce the hard sheet consumption in the packaging process of Suhuang cough capsule automatic packaging line | Solid preparation workshop |
Spearhead QC team | Reduce the failure rate of BHD-260 automatic packing machine | Equipment engineering department |
Starfish QC Team | The content of isomer A and isomer B in S raw material was decreased | Institute of Pharmaceutical research |
Haiyue QC Team | Improve the stability of related substances of injection M products | Institute of Pharmaceutical research |
Shared QC team | Increase the utilization rate of fixed assets | Financial department |
Up to now, Beijing Haiyan Pharmaceutical has carried out more than 20 key research activities. In the future, Beijing Haiyan Pharmaceutical Co., Ltd. will continue to vigorously carry out QC group activities, making it a normal management mode for enterprises to control quality, improve quality, and promote the construction and improvement of quality system across the board, so that QC group activities can promote enterprise reform and innovation and excellent development at a higher level and at a higher level.
Home